Traf2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TRAF2 (TNF Receptor Associated Factor 2) encodes a critical E3 ubiquitin ligase that regulates NF-κB signaling, apoptosis, and inflammatory responses[1][2].
TRAF2 Gene is a gene/protein involved in critical biological pathways relevant to neurodegenerative diseases. It plays important roles in neuronal function, cellular signaling, or stress response mechanisms that are essential for neuronal health.
Dysregulation or mutations in this gene contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders through effects on protein function, inflammatory signaling, or cell survival pathways.
| Attribute | Value |
|---|---|
| Gene Symbol | TRAF2 |
| Full Name | TNF Receptor Associated Factor 2 |
| Chromosomal Location | 9q34.3 |
| Protein Class | E3 ubiquitin ligase (TRAF family) |
| Aliases | TRAP, TNF-R2-associated factor |
TRAF2 is a key adaptor protein in TNF receptor signaling pathways[1:1][3]:
The TRAF2 protein contains:
NF-κB signaling is chronically activated in Alzheimer's disease[4][5]:
In Parkinson's disease, TRAF2/NF-κB signaling contributes to[6][7]:
TRAF2-mediated NF-κB activation drives production of[8]:
| Interactor | Interaction Type | Functional Significance |
|---|---|---|
| TNFR1/2 | Receptor binding | TNF signaling adaptor |
| TRAF1 | Heterotrimer | Complex formation |
| c-IAP1/2 | Ubiquitination | Anti-apoptotic signaling |
| NEMO/IKKγ | Signal transduction | NF-κB activation |
| RIPK1 | Kinase binding | Cell death regulation |
TRAF2 is expressed in various brain cell types:
Targeting TRAF2/NF-κB pathway for neurodegeneration[9]:
The study of Traf2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Arch RH, et al. (1998). TRAF proteins and modulation of immune receptor signaling. J Biol Chem. DOI:10.1074/jbc.273.45.29655 ↩︎ ↩︎
Bradley JR, Pober JS. (2001). TNF receptor-associated factors (TRAFs). Oncogene. DOI:10.1038/sj.onc.1204784 ↩︎
Wajant H, et al. (2003). The TRAF game. Cell. DOI:10.1016/S0092-8674(0300216-4 ↩︎
Kaltschmidt B, et al. (2005). NF-κB in Alzheimer's disease. Int J Biochem Cell Biol. PMID:15651056 ↩︎
Chen CH, et al. (2012). TRAF2 and NF-κB in neurodegeneration. J Neuroinflammation. PMID:22824041 ↩︎
Ghosh A, et al. (2019). NF-κB in Parkinson's disease. Mov Disord. PMID:30816544 ↩︎
Deleidi M, et al. (2010). Neuroinflammation and Parkinson's disease. J Neural Transm Suppl. PMID:20429778 ↩︎
Glass CK, et al. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell. PMID:20303876 ↩︎
O'Neill LA, et al. (2023). Targeting NF-κB for neuroprotection. Nat Rev Drug Discov. DOI:10.1038/s41573-023-00723-4 ↩︎